|
Delayed
NYSE
03:31:41 29/10/26 am AEDT
|
5-day change | 1st Jan Change | ||
| 43.53 USD | +3.64% |
|
+1.87% | +66.09% |
Main features
| US46435U1925 | Fees | 0.47% | Dividend Policy | Distribution | |
|---|---|---|---|---|---|
| Currency | USD | AuM (AUD) | 341.02M | Replication Method | Direct (Physical) |
| Number of securities | 52 | AuM evolution | - | Date of creation | 11/06/2019 |
NYSEUSD
| Markets | Quality | ||
|---|---|---|---|
CBOE
| IDNA | Real-time | |
NYSE
| IDNA | Delayed |
Easily sort and filter through all available ETFs
Access the ETF ScreenerEconomic news
Investment objective
| Asset Classes | Stocks |
|---|---|
| Geographical Focus | - |
| Theme and Sector | BioTech & Genomics |
The iShares Genomics Immunology and Healthcare ETF seeks to track the investment results of an index composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology, and bioengineering.
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/10/26 | USD 43.53 | +3.64% | 61,631 |
| 27/10/26 | USD 42.00 | +2.56% | 72,459 |
| 26/10/26 | USD 40.95 | +0.10% | 60,190 |
| 23/10/26 | USD 40.91 | -0.32% | 76,002 |
| 22/10/26 | USD 41.04 | -3.89% | 304,430 |
- Stock Market
- ETF
- IDNA ETF
Select your edition
All financial news and data tailored to specific country editions

























